Boehringer Ingelheim

NEWS DESK

Boehringer Ingelheim earns Global and Middle East Top Employer for 2026

News Desk 16/01/2026

Boehringer Ingelheim, one of the world’s leading biopharmaceutical companies, has been recognized as Top Employer Middle East for the third consecutive year, reflecting a sustained and deliberate focus on how people are supported, developed, and enabled to do their best work. This year’s

NEWS DESK

DoH and Boehringer Ingelheim Ink Strategic Partnership to Advance Life Science Innovation Across the Emirate

PR News Desk 17/06/2025

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, one of the world’s leading research-driven pharmaceutical companies. This strategic partnership aims to advance scientific research and innovation, foster groundbreaking research and development

NEWS DESK

Abu Dhabi Public Health Centre and Boehringer Ingelheim Partner to Combat Chronic Diseases in the UAE

PR News Desk 17/05/2025

The Abu Dhabi Public Health Centre (ADPHC), an affiliate of the Department of Health – Abu Dhabi (DoH), has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, a global leader in the pharmaceutical industry, to enhance health outcomes for patients living with chronic diseases in the Emirate. The partnership aims to improve the quality […]

NEWS DESK

Boehringer Ingelheim Launches Fast-acting Stroke Medication in the UAE

PR News Desk 27/02/2025

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has launched a new acute ischemic stroke (AIS) medication with active ingredient Tenecteplase 25mg to enhance emergency stroke treatment in the UAE, offering a faster and more effective treatment option for emergency stroke care. Launched in the UAE for the first time across the India, Middle East,

NEWS DESK

Dubai Miracle Garden Blooms with Hope as Boehringer Ingelheim Concludes Interstitial Lung Disease Awareness Campaign

PR News Desk 25/02/2025

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has collaborated with Emirates Thoracic Society (ETS) and social media influencer Ghaith Marwan, to raise awareness of Interstitial Lung Disease (ILD) through a community engagement initiative achieving 1 million steps and culminating in a breathtaking installation unveiling at Dubai Miracle Garden

NEWS DESK

Ministry of Health Saudi Arabia and Boehringer Ingelheim Strengthen Collaboration

PR News Desk 26/11/2024

Boehringer Ingelheim has signed a Memorandum of Understanding (MoU) with the Ministry of Health (MOH) in the Kingdom of Saudi Arabia (KSA) to expand its Angels Initiative telestroke services through Seha Virtual Hospital in efforts to enhance local stroke management and improve health outcomes for stroke patients in the Kingdom. The MoU was signed on […]

NEWS DESK

Boehringer Ingelheim Launches Broadest Spectrum Parasiticide for Cats in the UAE

PR News Desk 03/10/2024

Boehringer Ingelheim has launched a breakthrough monthly  parasiticide solution for cats in the UAE, to ensure convenient and comprehensive protection for cats and cat owners. The solution combines esafoxolaner for fleas and ticks, and eprinomectin and praziquantel for internal parasites, delivering a broad-spectrum of protection against fleas, ticks, mites, worms,